+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class; Route of Administration; Distribution Channel; and Country

  • PDF Icon

    Report

  • 105 Pages
  • August 2020
  • Region: Europe
  • The Insight Partners
  • ID: 5147232
UP TO OFF until Mar 31st 2024
The Europe Chronic Cough market is projected to reach US$ 2,881.55 million by 2027 from US$ 1,647.94 million in 2019; it is estimated to grow with a CAGR of 7.3% from 2020 to 2027.

The growth of the chronic cough market is primarily attributed to rising incidences of chronic cough, growing product developments to treat chronic cough. More over the rising outbreak of the COVID-19 pandemic has highly affected the countries in the Europe n region and the chronic cough market in the region.

The developments in the pharmaceutical and biopharmaceutical industry for the drugs that can treat chronic cough are likely to lead the market growth. Additionally, Chronic cough is caused due to asthma, acid reflux from the stomach, and postnasal drip. The conditions such as infection, bronchitis, and lung diseases are also likely to lead to chronic cough. The condition of asthma is rising across the world; it is commonly seen among children and adults. It is a significant cause of the growing health burden in the regions. For, or instance, as per the study published by the Pharmaceutical Services Negotiating Committee (PSNC), the UK among the countries in the region, has high asthma death rates. It is an estimated increase in the rate of death due to an asthma attack above 20% in five years. This rising prevalence of diseases associated with chronic cough has an impact on the market in the region.

In 2019, the drug class segment accounted for a larger share of the Europe chronic cough market. Its growth is attributed to growing product developments to treat chronic cough. Additionally, rising incidences of chronic cough likely to drive the growth of drug class segment in the Europe chronic cough market.

A few major primary and secondary sources for the chronic cough market included in the report are European Respiratory Society, Centers for Disease Control and Prevention, are among the others.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Chronic Cough Market - By Drug Class
1.3.2 Chronic Cough Market - By Route of Administration
1.3.3 Chronic Cough Market - By Distribution Channel
1.3.4 Europe Chronic Cough Market - By Country
2. Chronic Cough Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Chronic Cough Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Chronic Cough Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic Cough
5.1.2 Growing Product Developments to Treat Chronic Cough
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Aging Population is Expected to Drive Demand for Chronic Cough Treatment
5.4 Future Trends
5.4.1 Continuous Trend of Drug Development
5.5 Impact Analysis
6. Chronic Cough Market Analysis - By Drug Class
6.1 Overview
6.2 Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
6.3 Antihistamines
6.3.1 Overview
6.3.2 Antihistamines: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
6.4 Corticosteroids
6.4.1 Overview
6.4.2 Corticosteroids: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
6.5 Decongestants
6.5.1 Overview
6.5.2 Decongestants: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
6.6 Combination Drug
6.6.1 Overview
6.6.2 Combination Drug: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
6.7 Antibiotics
6.7.1 Overview
6.7.2 Antibiotics: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
6.8 Acid Blockers
6.8.1 Overview
6.8.2 Acid Blockers: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
6.9 Other Drug Class
6.9.1 Overview
6.9.2 Other Drug Class: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
7. Chronic Cough Market - By Route of Administration
7.1 Overview
7.2 Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
7.3 Oral
7.3.1 Overview
7.3.2 Oral: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Injections
7.4.1 Overview
7.4.2 Injections: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Inhalation
7.5.1 Overview
7.5.2 Inhalation: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Other Route of Administration
7.6.1 Overview
7.6.2 Other Route of Administration: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
8. Chronic Cough Market - By Distribution Channel
8.1 Overview
8.2 Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacy
8.3.1 Overview
8.3.2 Hospital Pharmacy: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Online Pharmacy
8.4.1 Overview
8.4.2 Online Pharmacy: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Retail Pharmacy
8.5.1 Overview
8.5.2 Retail Pharmacy: Chronic Cough Market - Revenue and Forecast to 2027 (US$ Million)
9. Chronic Cough Market - Regional Analysis
9.1 Europe: Chronic Cough Market
9.1.1 Overview
9.1.2 Europe: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Europe: Chronic Cough Market, by Drug Class, 2018-2027 (USD Million)
9.1.4 Europe: Chronic Cough Market, by Route of Administration, 2018-2027 (USD Million)
9.1.5 Europe: Chronic Cough Market, by Distribution Channel, 2018-2027 (USD Million)
9.1.6 Europe: Chronic Cough Market, by Country, 2018 & 2027 (%)
9.1.7 Germany: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Germany: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Germany: Chronic Cough Market, by Drug Class, 2018-2027 (USD Million)
9.1.7.3 Germany: Chronic Cough Market, by Route of Administration, 2018-2027 (USD Million)
9.1.7.4 Germany: Chronic Cough Market, by Distribution Channel, 2018-2027 (USD Million)
9.1.8 UK: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 UK: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 UK: Chronic Cough Market, by Route of Administration, 2018-2027 (USD Million)
9.1.8.3 UK: Chronic Cough Market, by Distribution Channel, 2018-2027 (USD Million)
9.1.9 France: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.1 France: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.2 France: Chronic Cough Market, by Drug Class, 2018-2027 (USD Million)
9.1.9.3 France: Chronic Cough Market, by Route of Administration, 2018-2027 (USD Million)
9.1.9.4 France: Chronic Cough Market, by Distribution Channel, 2018-2027 (USD Million)
9.1.10 Spain: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Spain: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Spain: Chronic Cough Market, by Drug Class, 2018-2027 (USD Million)
9.1.10.3 Spain: Chronic Cough Market, by Route of Administration, 2018-2027 (USD Million)
9.1.10.4 Spain: Chronic Cough Market, by Distribution Channel, 2018-2027 (USD Million)
9.1.11 Italy: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Italy: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Italy: Chronic Cough Market, by Drug Class, 2018-2027 (USD Million)
9.1.11.3 Italy: Chronic Cough Market, by Route of Administration, 2018-2027 (USD Million)
9.1.11.4 Italy: Chronic Cough Market, by Distribution Channel, 2018-2027 (USD Million)
10. Impact of COVID-19 Pandemic on Regional Chronic cough Market
10.1 Europe: Impact Assessment Of COVID-19 Pandemic
11. COMPANY PROFILES
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 MYLAN N.V.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Amneal Pharmaceuticals, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Cipla Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Reckitt Benckiser Group plc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Sun Pharmaceutical Industries Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Aurobindo Pharma Ltd
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary of Terms
List of Tables
Table 1. Europe Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 2. Europe Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 3. Europe Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 4. Germany Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 5. Germany Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 6. Germany Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 7. UK Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 8. UK Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 9. UK Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 10. France Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. France Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 12. France Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 13. Spain Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 14. Spain Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 15. Spain Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 16. Italy Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 17. Italy Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)
Table 18. Italy Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)
Table 19. Glossary of Terms, Chronic Cough Market
List of Figures
Figure 1. Chronic Cough Market Segmentation
Figure 2. Chronic Cough Market – By Country
Figure 3. Europe Chronic Cough Market Overview
Figure 4. Combination Drug Segment Held Largest Share of Chronic Cough Market
Figure 5. UK to Show Remarkable Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Expert Opinion
Figure 8. Chronic Cough Market Impact Analysis of Drivers and Restraints
Figure 9. Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)
Figure 10. Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)
Figure 18. Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)
Figure 23. Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Europe: Chronic Cough Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. Europe Chronic Cough Market Revenue and Forecast to 2027 (USD Million)
Figure 28. Europe: Chronic Cough Market, by Country, 2018 & 2027 (%)
Figure 29. Germany: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. UK: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. France: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Spain: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Italy: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in European Country Markets

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Bayer AG
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd